MedTrace Logo

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

NCT01484262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1344

Last updated 2018-11-01

No results posted yet for this study

Summary

This study is conducted in Europe. The intention of this health service research study is to obtain data from daily routine to evaluate the quality of life and the costs of the disease for patients with type 2 diabetes mellitus.

Conditions

Interventions

DRUG

liraglutide

Patients will be treated according to routine clinical practice at the discretion of the treating physician according to current labelling.

DRUG

insulin

Any insulin in any device available on the market may be used by patients as part of routine clinical practice according to current labelling.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-14
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01484262 on ClinicalTrials.gov